Proprietary AI analyst is now available

Kusuri No Aoki Valuation Multiples

Discover revenue and EBITDA valuation multiples for Kusuri No Aoki and similar public comparables like Selçuk Ecza, Ebos Group, Dis-Chem Pharmacies, Omnicell and more.

Kusuri No Aoki Overview

About Kusuri No Aoki

Kusuri No Aoki Holdings is a pharmaceutical retail chain that sells health, beauty, and cleaning supplies. The company operates stores that focus primarily on residential areas in Japan. Kusuri's business includes pharmaceutical drugs, and the company also operates a bone-marrow bank. The company breaks out its sales into four different product lines, including health, beauty, life, and dispensing. The vast majority of the company's revenue is derived from its life product category, followed by beauty products. Most of Kusuri's revenue is derived from the Hokuriku region.


Founded

1999

HQ

Japan

Employees

8.0K

Sectors

Financials (LTM)

Revenue: $4B
EBITDA: $253M

EV

$3B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Kusuri No Aoki Financials

Kusuri No Aoki reported last 12-month revenue of $4B and EBITDA of $253M.

In the same LTM period, Kusuri No Aoki generated $928M in gross profit, $253M in EBITDA, and $114M in net income.

Revenue (LTM)


Kusuri No Aoki P&L

In the most recent fiscal year, Kusuri No Aoki reported revenue of $3B and EBITDA of $270M.

Kusuri No Aoki is profitable as of last fiscal year, with gross margin of 24%, EBITDA margin of 8%, and net margin of 4%.

See analyst estimates for Kusuri No Aoki
LTMLast FY202320242025202620272028
Revenue$4B$3B$3B$3B$3B
Gross Profit$928M$829M$705M$790M$884M
Gross Margin26%24%27%27%26%
EBITDA$253M$270M$191M$226M$249M
EBITDA Margin7%8%7%8%7%
EBIT Margin5%5%4%5%5%
Net Profit$114M$123M$77M$97M$112M
Net Margin3%4%3%3%3%
Net Debt-$284M---

Financial data powered by Morningstar, Inc.

Kusuri No Aoki Stock Performance

Kusuri No Aoki has current market cap of $2B, and enterprise value of $3B.

Market Cap Evolution


Kusuri No Aoki's stock price is $22.50.

Kusuri No Aoki share price increased by 3.4% in the last 30 days, and decreased by 1.9% in the last year.

Kusuri No Aoki has an EPS (earnings per share) of $1.30.

See more trading valuation data for Kusuri No Aoki
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$3B$2B-1.4%3.4%-7.7%-1.9%$1.30

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Kusuri No Aoki Valuation Multiples

Kusuri No Aoki trades at 0.8x EV/Revenue multiple, and 10.6x EV/EBITDA.

See NTM and 2027E valuation multiples for Kusuri No Aoki

EV / Revenue (LTM)


Kusuri No Aoki Financial Valuation Multiples

As of June 18, 2026, Kusuri No Aoki has market cap of $2B and EV of $3B.

Kusuri No Aoki has a P/E ratio of 18.8x.

LTMLast FY202320242025202620272028
EV/Revenue0.8x0.8x1.0x0.9x0.8x
EV/EBITDA10.6x9.9x14.1x11.9x10.8x
EV/EBIT16.2x14.6x25.0x18.5x16.2x
EV/Gross Profit2.9x3.2x3.8x3.4x3.0x
P/E18.8x17.4x27.8x22.1x19.0x
EV/FCFn/mn/m54.5x158.9xn/m

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Kusuri No Aoki Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Kusuri No Aoki Margins & Growth Rates

Kusuri No Aoki grew revenue by 2% but EBITDA decreased by 7% in the last fiscal year.

In the most recent fiscal year, Kusuri No Aoki reported gross margin of 24%, EBITDA margin of 8%, and net margin of 4%.

See estimated margins and future growth rates for Kusuri No Aoki

Kusuri No Aoki Margins

Last FY202420252026202720282029
Gross Margin24%27%26%26%
EBITDA Margin8%8%7%7%
EBIT Margin5%5%5%5%
Net Margin4%3%3%3%
FCF Margin(0%)1%(0%)(0%)

Kusuri No Aoki Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth2%15%14%13%
Gross Profit Growth11%12%12%10%
EBITDA Growth(7%)18%10%5%
EBIT Growth(10%)35%14%4%
Net Profit Growth(8%)26%16%6%
FCF Growth2606%(66%)(126%)(76%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Kusuri No Aoki Operational KPIs

Kusuri No Aoki's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.

Kusuri No Aoki's Rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Kusuri No Aoki's Rule of X is 38% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Kusuri No Aoki
LTMLast FY202320242025202620272028
Rule of 4019%19%---
Bessemer Rule of X37%38%---
Revenue per Employee-$0.4M---
Opex per Employee-$0.1M---
Opex to Revenue-19%23%22%20%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Kusuri No Aoki Competitors

Kusuri No Aoki competitors include Selçuk Ecza, Ebos Group, Dis-Chem Pharmacies, Omnicell, Fragua, DaShenLin Pharmaceutical, Sundrug, Redcare Pharmacy, LBX Pharmacy and Create SD Holdings.

Most Kusuri No Aoki public comparables operate across Pharmacies.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Selçuk Ecza0.4x0.4x16.4x10.7x
Ebos Group0.4x0.4x9.1x8.0x
Dis-Chem Pharmacies0.8x0.8x10.9x10.6x
Omnicell1.4x1.4x12.1x11.3x
Fragua0.3x0.3x6.6x4.1x
DaShenLin Pharmaceutical0.6x0.6x4.7x4.8x
Sundrug0.5x0.5x6.8x6.2x
Redcare Pharmacy0.5x0.5x25.4x20.4x

This data is available for Pro users. Sign up to see all Kusuri No Aoki competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Kusuri No Aoki

When was Kusuri No Aoki founded?Kusuri No Aoki was founded in 1999.
Where is Kusuri No Aoki headquartered?Kusuri No Aoki is headquartered in Japan.
How many employees does Kusuri No Aoki have?As of today, Kusuri No Aoki has over 8K employees.
Is Kusuri No Aoki publicly listed?Yes, Kusuri No Aoki is a public company listed on Tokyo Stock Exchange.
What is the stock symbol of Kusuri No Aoki?Kusuri No Aoki trades under 3549 ticker.
When did Kusuri No Aoki go public?Kusuri No Aoki went public in 2006.
Who are competitors of Kusuri No Aoki?Kusuri No Aoki main competitors include Selçuk Ecza, Ebos Group, Dis-Chem Pharmacies, Omnicell, Fragua, DaShenLin Pharmaceutical, Sundrug, Redcare Pharmacy, LBX Pharmacy, Create SD Holdings.
What is the current market cap of Kusuri No Aoki?Kusuri No Aoki's current market cap is $2B.
What is the current revenue of Kusuri No Aoki?Kusuri No Aoki's last 12 months revenue is $4B.
What is the current revenue growth of Kusuri No Aoki?Kusuri No Aoki revenue growth (NTM/LTM) is 12%.
What is the current EV/Revenue multiple of Kusuri No Aoki?Current revenue multiple of Kusuri No Aoki is 0.8x.
What is the current EBITDA of Kusuri No Aoki?Kusuri No Aoki's last 12 months EBITDA is $253M.
What is Kusuri No Aoki's EBITDA margin?Kusuri No Aoki's last 12 months EBITDA margin is 7%.
What is the current EV/EBITDA multiple of Kusuri No Aoki?Current EBITDA multiple of Kusuri No Aoki is 10.6x.
What is the current FCF of Kusuri No Aoki?Kusuri No Aoki's last 12 months FCF is ($7M).
What is Kusuri No Aoki's FCF margin?Kusuri No Aoki's last 12 months FCF margin is (0%).
What is the current EV/FCF multiple of Kusuri No Aoki?Current FCF multiple of Kusuri No Aoki is (399.2x).
How many companies Kusuri No Aoki has acquired to date?Kusuri No Aoki hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Kusuri No Aoki has invested to date?Kusuri No Aoki hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Kusuri No Aoki

Lists including Kusuri No Aoki

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial